This site is intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Information on how to access prescribing information and adverse event reporting can be found at the bottom of the page.

Stewardship

Pfizer leads across stewardship metrics and is ranked among top two large R&D pharmaceutical companies in the fight against antimicrobial resistance (AMR)*1

The 2020 AMR Benchmark highlighted key areas of our leadership, including:

Pfizer is ranked first across stewardship metrics. Through a pilot established in 2019, Pfizer fully decoupled sales bonuses from volumes for antibacterial and antifungal medicines in the UK and partially decoupled bonuses from sales volumes in other countries. Pfizer was also recognized as the first company to share raw data on resistance collected via our open-access ATLAS surveillance program.1
Pfizer is a leading company when it comes to filing relevant on-patented products for registration in low- and middle-income countries and taking steps to ensure continuous supply.1
Pfizer is one of the few large research-based pharmaceutical companies still active in R&D for antibacterial medicines and vaccines.1
Pfizer has a comprehensive environmental risk-management strategy for our manufacturing sites, and those of our suppliers, to limit AMR.1

Educational Resources

We have a variety of educational resources aimed at supporting Healthcare Professsionals looking to enhance their knowledge of AMR and Stewardship.

Access resources

*The Access to Medicine Foundation AMR Report

The Access to Medicine Foundation published its 2020 Antimicrobial Resistance Benchmark in February 2020. The bi-yearly report evaluates our industry’s progress in the fight against antimicrobial resistance (AMR). The Foundation's Benchmark provides an independent comparison of 30 pharmaceutical research companies' efforts to curb AMR across three research areas: research and development, manufacturing and production, and appropriate access and stewardship.

Download Report

About Access to Medicine Foundation

The Access to Medicine Foundation is an independent non-profit organization based in the Netherlands. It aims to advance access to medicine in low- and middle-income countries by stimulating and guiding the pharmaceutical industry to play a greater role in improving access to medicine.​​​​​​​1

Educational Resources

'Bye Bye Bugs' Educational App

The Pfizer medical team launched an anti-infectives educational app, Bye Bye Bugs, in September 2018 via the UK Apple App store. It is a free educational game designed for junior Healthcare Professionals (HCPs) or senior HCPs who want to enhance their Antimicrobial Stewardship knowledge. The game simulates a virtual hospital-like scenario; through patient-based scenarios players diagnose infections and choose antimicrobial treatments. Feedback on decisions aims to improve learning and help understand the consequences of inappropriate antimicrobial treatment.

Card CTA

** This is an optional area where footnotes can live.

Bye Bye Bugs - QR code

Scan the QR Code to download the app

British Society for Antimicrobial Chemotherapy (BSAC) Antimicrobial Stewardship Massive Open Online Courses (MOOC)

We are proud to sponsor a collaboration with the British Society for Antimicrobial Chemotherapy and the University of Dundee on the development of an online educational course for healthcare professionals on antibiotic stewardship.2 Pfizer were the main consortium sponsor for the BSAC Antimicrobial Stewardship (AMS) MOOC when it launched in 2015, over 53,500 participants have enrolled for the AMS MOOC from over 200 countries. In addition, the AMS MOOC has been translated into a number of languages including Russian, Chinese and Portuguese. The AMS MOOC is just one of the BSAC educational programmes that Pfizer have sponsored. 

Antimicrobial Susceptibility Testing (AST)

Launched in 2017, the Pfizer UK Antibiotic Susceptibility Testing (AST) programme provides NHS Trusts access to AST diagnostics in order to ensure responsible prescribing and support appropriate stewardship of our anti-infectives. The AST programme allows clinicians to inform their patient therapy decisions using commercially available AST diagnostic tests, and therefore to prescribe antibiotics appropriately. This will also help to protect the useful life of the antibiotic (from antibiotic resistance) by ensuring hospitals can exert appropriate stewardship. 

If you would like to speak with one of the Pfizer team about how we can provide additional support, please contact us here to request a call back or email.

Antimicrobial Stewardship Toolkit

The AMS Toolkit contains a variety of resources aimed to offer tips and advice to HCPs looking to implement and maintain an AMS programme within the secondary healthcare setting. To access and download these resources, please click here.​

AMS Lead Resource Pack - 'At a Glance'

Leading an AMS programme is a multi-faceted process requiring a coordinated response that engages colleagues and supports their active involvement. The items within this pack are designed to help you and your AMS Champions deliver excellent and consistent patient care through collaboration between all members of the hospital team.

Download

** This is an optional area where footnotes can live.

AMS Champion Resource Pack - 'At a Glance'

As an AMS Champion you play a key role in engaging with colleagues and supporting their active involvement with Antimicrobial Stewardship. The items within this pack are designed to help AMS Champions develop excellent and consistent patient care through collaboration with all members of the hospital team.

Download

** This is an optional area where footnotes can live.


References:
  1. Access to Medicine Foundation. Antimicrobial resistance benchmark 2020. Available at: https://accesstomedicinefoundation.org/media/uploads/downloads/5eeb623a17328_Antimicrobial_Resistance_Benchmark_2020.pdf [Last accessed July 2020]
  2. British Society for Antimicrobial Chemotherapy. Acknowledgements. Available at: http://www.bsac.org.uk/acknowledgements/ [Last Accessed May 2021]
PP-AIP-GBR-0799. September 2021

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-2688. December 2020

Yes

No